These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 23710622)

  • 1. Interfacial cavity filling to optimize CD4-mimetic miniprotein interactions with HIV-1 surface glycoprotein.
    Morellato-Castillo L; Acharya P; Combes O; Michiels J; Descours A; Ramos OH; Yang Y; Vanham G; Ariën KK; Kwong PD; Martin L; Kessler P
    J Med Chem; 2013 Jun; 56(12):5033-47. PubMed ID: 23710622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural basis for highly effective HIV-1 neutralization by CD4-mimetic miniproteins revealed by 1.5 Å cocrystal structure of gp120 and M48U1.
    Acharya P; Luongo TS; Louder MK; McKee K; Yang Y; Kwon YD; Mascola JR; Kessler P; Martin L; Kwong PD
    Structure; 2013 Jun; 21(6):1018-29. PubMed ID: 23707685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combinatorial optimization of a CD4-mimetic miniprotein and cocrystal structures with HIV-1 gp120 envelope glycoprotein.
    Stricher F; Huang CC; Descours A; Duquesnoy S; Combes O; Decker JM; Kwon YD; Lusso P; Shaw GM; Vita C; Kwong PD; Martin L
    J Mol Biol; 2008 Oct; 382(2):510-24. PubMed ID: 18619974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The HIV-1 Env gp120 Inner Domain Shapes the Phe43 Cavity and the CD4 Binding Site.
    Prévost J; Tolbert WD; Medjahed H; Sherburn RT; Madani N; Zoubchenok D; Gendron-Lepage G; Gaffney AE; Grenier MC; Kirk S; Vergara N; Han C; Mann BT; Chénine AL; Ahmed A; Chaiken I; Kirchhoff F; Hahn BH; Haim H; Abrams CF; Smith AB; Sodroski J; Pazgier M; Finzi A
    mBio; 2020 May; 11(3):. PubMed ID: 32457241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, antiviral activity and resistance of a novel small molecule HIV-1 entry inhibitor.
    Curreli F; Haque K; Xie L; Qiu Q; Xu J; Yong W; Tong X; Debnath AK
    Bioorg Med Chem; 2015 Dec; 23(24):7618-28. PubMed ID: 26602829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation and Inactivation of Primary Human Immunodeficiency Virus Envelope Glycoprotein Trimers by CD4-Mimetic Compounds.
    Madani N; Princiotto AM; Zhao C; Jahanbakhshsefidi F; Mertens M; Herschhorn A; Melillo B; Smith AB; Sodroski J
    J Virol; 2017 Feb; 91(3):. PubMed ID: 27881646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-activity relationships in the binding of chemically derivatized CD4 to gp120 from human immunodeficiency virus.
    Xie H; Ng D; Savinov SN; Dey B; Kwong PD; Wyatt R; Smith AB; Hendrickson WA
    J Med Chem; 2007 Oct; 50(20):4898-908. PubMed ID: 17803292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-based design, synthesis and validation of CD4-mimetic small molecule inhibitors of HIV-1 entry: conversion of a viral entry agonist to an antagonist.
    Courter JR; Madani N; Sodroski J; Schön A; Freire E; Kwong PD; Hendrickson WA; Chaiken IM; LaLonde JM; Smith AB
    Acc Chem Res; 2014 Apr; 47(4):1228-37. PubMed ID: 24502450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiniCD4 protein resistance mutations affect binding to the HIV-1 gp120 CD4 binding site and decrease entry efficiency.
    Grupping K; Selhorst P; Michiels J; Vereecken K; Heyndrickx L; Kessler P; Vanham G; Martin L; Ariën KK
    Retrovirology; 2012 May; 9():36. PubMed ID: 22551420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The C4 region as a target for HIV entry inhibitors--NMR mapping of the interacting segments of T20 and gp120.
    Moseri A; Biron Z; Arshava B; Scherf T; Naider F; Anglister J
    FEBS J; 2015 Dec; 282(24):4643-57. PubMed ID: 26432362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta-turn Phe in HIV-1 Env binding site of CD4 and CD4 mimetic miniprotein enhances Env binding affinity but is not required for activation of co-receptor/17b site.
    Dowd CS; Leavitt S; Babcock G; Godillot AP; Van Ryk D; Canziani GA; Sodroski J; Freire E; Chaiken IM
    Biochemistry; 2002 Jun; 41(22):7038-46. PubMed ID: 12033937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NMR studies on the conformation of the CD4 36-59 peptide bound to HIV-1 gp120.
    Gizachew D; Moffett DB; Busse SC; Westler WM; Dratz EA; Teintze M
    Biochemistry; 1998 Jul; 37(30):10616-25. PubMed ID: 9692951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computational studies identifying entry inhibitor scaffolds targeting the Phe43 cavity of HIV-1 gp120.
    Tintori C; Selvaraj M; Badia R; Clotet B; Esté JA; Botta M
    ChemMedChem; 2013 Mar; 8(3):475-83. PubMed ID: 23404750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Introducing metallocene into a triazole peptide conjugate reduces its off-rate and enhances its affinity and antiviral potency for HIV-1 gp120.
    Gopi H; Cocklin S; Pirrone V; McFadden K; Tuzer F; Zentner I; Ajith S; Baxter S; Jawanda N; Krebs FC; Chaiken IM
    J Mol Recognit; 2009; 22(2):169-74. PubMed ID: 18498083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short peptides with induced beta-turn inhibit the interaction between HIV-1 gp120 and CD4.
    Choi YH; Rho WS; Kim ND; Park SJ; Shin DH; Kim JW; Im SH; Won HS; Lee CW; Chae CB; Sung YC
    J Med Chem; 2001 Apr; 44(9):1356-63. PubMed ID: 11311058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, Antiviral Potency, in Vitro ADMET, and X-ray Structure of Potent CD4 Mimics as Entry Inhibitors That Target the Phe43 Cavity of HIV-1 gp120.
    Curreli F; Kwon YD; Belov DS; Ramesh RR; Kurkin AV; Altieri A; Kwong PD; Debnath AK
    J Med Chem; 2017 Apr; 60(7):3124-3153. PubMed ID: 28266845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tyrosine-sulfated V2 peptides inhibit HIV-1 infection via coreceptor mimicry.
    Cimbro R; Peterson FC; Liu Q; Guzzo C; Zhang P; Miao H; Van Ryk D; Ambroggio X; Hurt DE; De Gioia L; Volkman BF; Dolan MA; Lusso P
    EBioMedicine; 2016 Aug; 10():45-54. PubMed ID: 27389109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histidine 375 Modulates CD4 Binding in HIV-1 CRF01_AE Envelope Glycoproteins.
    Zoubchenok D; Veillette M; Prévost J; Sanders-Buell E; Wagh K; Korber B; Chenine AL; Finzi A
    J Virol; 2017 Feb; 91(4):. PubMed ID: 27928014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Naturally occurring variability in the envelope glycoprotein of HIV-1 and development of cell entry inhibitors.
    Brower ET; Schön A; Freire E
    Biochemistry; 2010 Mar; 49(11):2359-67. PubMed ID: 20166763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Range of CD4-Bound Conformations of HIV-1 gp120, as Defined Using Conditional CD4-Induced Antibodies.
    Kaplan G; Roitburd-Berman A; Lewis GK; Gershoni JM
    J Virol; 2016 May; 90(9):4481-4493. PubMed ID: 26889042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.